Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
Global women's health executive to lead Arletta in its development strategy focused on advancing Lybrido™'s (sildenafil/testosterone) Phase 2 MONARCH study following positive FDA correspondence Effective September 1, 2026 Over 30 years of…
Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
Sun Pharmaceutical Industries will extend Most Favoured Nation (MFN) pricing to state medicaid programmes of the U.S. It has also committed to MFN pricing for future innovative medicine launches. The announcement followed a White House ceremony on…
Pressure mounts on Europe as Trump deals push pharma to the US
Industry leaders in Europe warn that if the U.S. continues to sign more deals with companies — designed to drive down prices for American citizens while boosting U.S. investments — European patients will feel the effects. Since the…
Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials
shares rose after the drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis, saying its new pill helped patients experience fewer flare-ups. Shares in Novartis were up 4.5% in European midday…
Sun Pharma signs US MFN pricing agreement for Medicaid programmes
India's Sun Pharmaceutical Industries is among nine drugmakers that have signed an agreement with the United States government to extend “Most Favoured Nation” (MFN) pricing in America. The company said it would extend MFN pricing to…
NIO's Loss Narrows on EV Sales Growth
Chinese electric-vehicle maker reported a narrower loss in the second quarter, thanks to robust deliveries and its premium positioning, though the sequential decline in monthly sales weighed on shares. Its net loss came to 721.6 million yuan…
Ascentage Pharma Group International (NASDAQ:AAPG) Reaches New 52-Week Low - Here's What Happened
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) hit a new 52-week low during trading on Tuesday. The stock traded as low as $16.23 and last traded at $16.23, with a volume of 7070 shares. The stock…
Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of 'Buy' from Brokerages
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have earned a consensus recommendation of 'Buy' from the twenty ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with…
Stock market today: Dow, S&P 500, Nasdaq futures fall as inflation, Fed rate-hike fears persist
US stock futures meandered on Tuesday morning as uncertainty around the war in Iran, the bond market, and the Fed's next interest rate move largely kept buyers on the sidelines. Futures on the Dow Jones Industrial Average (YM=F) and S&P 500 (ES=F)…
Trump's Drug Pricing Push Now Covers 89 Percent of Branded Market
President Donald Trump just added nine more drug companies to his Most-Favored-Nation (MFN) pricing push. That brings the total to 26 companies, covering 89 percent of the branded drug market. The new agreements are with Alcon, Astellas Pharma…
Symbiotec Pharmalab IPO: Shares rebound after initial dip on market debut
Symbiotec Pharmalab Ltd, a leading pharma and biotech company, experienced a volatile market debut, initially listing lower before rebounding strongly, following its highly oversubscribed initial public offering. Symbiotec Pharmalab Ltd shares…
Novartis: Today's Positive Remibrutinib Data Key To Unlocking Growth Plans (NYSE:NVS)
Novartis AG shared positive data in relation to its key pipeline asset remibrutinib earlier today. The NVS drug met the primary endpoint in two Phase 3 clinical studies in patients suffering from multiple sclerosis ('MS'), showing superiority vs…
CSL signs deal with Trump administration to slash prices for its medicines
Australia's largest pharma company CSL said it has signed agreements with the Trump administration to lower the cost of its medicines in the United States as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals…
What Trump's Most-Favored-Nation Deal Means for Drug Prices
The Trump Administration on Aug. 31 announced that nine mid-sized pharmaceutical companies had agreed to lower the prices that Medicaid programs pay for drugs, bringing the total number of companies that made deals to lower prices to 26. The…
Hafnia Stock: Hormuz Keeps The Q4 Upside Alive (NYSE:HAFN)
Hafnia Limited is rated Buy, driven by a strong Q2, low leverage, and a high variable dividend payout. Approximately 74% of HAFN's Q4 own-fleet days remain open to a highly profitable spot market, offering significant earnings sensitivity to…
Receive a Daily briefing on Pharma Industry News
Get Started